Navigation Links
Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

-Company's New Name is PROLOR Biotech, Inc.-

-Will Now Trade under New Ticker PBTH-

-Shareholders Approve Re-Election of Board of Directors and Other Proposals-

NES-ZIONA, Israel, June 12 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today announced that shareholders approved a proposal to change the company's name to PROLOR Biotech, Inc. at its Annual Meeting of Shareholders held on May 21, 2009. The corporate name change became effective on Wednesday, June 10, 2009. Starting on Friday, June 12, 2009, the company's shares will trade on the OTC Bulletin Board under the symbol PBTH.

In addition to the new corporate name, shareholders re-elected all members of the company's Board of Directors, approved an amendment to the company's 2007 Equity Incentive Plan and ratified Yarel + Partners as the company's independent registered public accounting firm.

"Our new name, PROLOR Biotech--PROtein LOngevity Redefined--reflects our company's unique CTP technology that has been proven to significantly extend the longevity and biological activity of major therapeutic proteins such as follicle stimulating hormone, human growth hormone, interferon beta, erythropoietin, Factor VII and Factor IX, and potentially any other therapeutic protein," said Shai Novik, president of PROLOR Biotech. "It is fitting that we make this change now as we prepare to initiate our first clinical trial with our longer-acting version of human growth hormone, signalling our transformation into a clinical stage company."


PROLOR Biotech, Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and PROLOR Biotech is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information, visit After July 15, 2009, the company's website can be found at

    PROLOR Biotech CONTACT:                   MEDIA CONTACT:
    Shai Novik, President                     Barbara Lindheim
    PROLOR Biotech, Inc.                      GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                      +1 212 918-4650

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Modigene to Present at the Roth 2007 New York Investor Conference
2. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
4. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Modigene to Present at the UBS Global Life Sciences Conference
6. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
7. Modigene Sets Record Date for Annual Meeting of Shareholders
8. Modigene to Present at the BIO-Europe Spring(R) 2009 Conference
9. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
10. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
11. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
Post Your Comments:
(Date:11/30/2015)... 2015  Aytu BioScience, Inc. (OTCQB: AYTU), a commercial-stage ... will present at two upcoming investor conferences. Aytu is ... virtual conference, to be held December 3, 2015, and ... held December 2 nd & 3 rd , ... streamed live via webcast. Josh Disbrow , ...
(Date:11/30/2015)... TIKVAH, Israel , Nov. 30, 2015 /PRNewswire/ ... a leading developer of adult stem cell technologies for neurodegenerative ... Ltd., has been awarded an additional grant of approximately $735,000 ... Scientist (OCS). This grant, the second this year, brings the ... approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
Breaking Biology Technology:
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
(Date:10/27/2015)... Oct. 27, 2015 In the present market ... concern for various industry verticals such as banking, healthcare, ... the growing demand for secure & simplified access control ... such as hacking of bank accounts, misuse of users, ... such as PC,s, laptops, and smartphones are expected to ...
(Date:10/26/2015)... , Oct. 26, 2015  Delta ID Inc., a ... to mobile and PC devices, announced its ActiveIRIS® technology ... arrows NX F-02H launched by NTT DOCOMO, INC in ... is the second smartphone to include iris recognition technology, ... ARROWS NX F-04G in May 2015, world,s first smartphone ...
Breaking Biology News(10 mins):